Immunological lessons from CD28 deficiency in humans

Area of Science:

• Immunology and Molecular Biology
• Human Genetics and Infectious Diseases

Background:

• T-cell co-stimulation is crucial for adaptive immunity.
• CD28 is a key T-cell co-stimulatory molecule essential for immune responses.
• Genetic deficiencies in immune molecules can lead to severe clinical manifestations.

Purpose of the Study:

• To investigate the clinical and immunological consequences of a mutation causing CD28 deficiency.
• To analyze the susceptibility to specific viral infections in individuals with CD28 deficiency.
• To evaluate the impact of CD28 deficiency on vaccine efficacy.

Main Methods:

• Clinical case study of three affected family members.
• Molecular genetic analysis to identify the mutation.
• Immunological assays to assess T-cell function and viral loads.

Main Results:

• Identified a mutation leading to a deficiency of the T-cell co-stimulatory molecule CD28.
• Patients exhibited severe clinical symptoms, including infections with human papillomavirus-2 and -4.
• Elevated levels of Epstein-Barr virus and cytomegalovirus were detected, alongside a poor response to vaccinations.

Conclusions:

• CD28 deficiency severely impairs the immune system, leading to susceptibility to opportunistic viral infections.
• The findings underscore the critical role of CD28 in maintaining immune homeostasis and effective vaccine responses.
• This study provides critical insights into the pathogenesis of CD28-related immunodeficiency.